Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 9

Results: 26

Correction to: Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer.

Published in:

2021

By:

Saleh, Reem;
Nair, Varun Sasidharan;
Murshed, Khaled;
Nada, Mohamed Abu;
Elkord, Eyad;
Shaheen, Ranad

Publication type:

Correction Notice

First time intravesically administered trifunctional antibody catumaxomab in patients with recurrent non-muscle invasive bladder cancer indicates high tolerability and local immunological activity.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2727, doi. 10.1007/s00262-021-02930-7

By:

Ruf, Peter;
Bauer, Hartwig W.;
Schoberth, Alexandra;
Kellermann, Claudia;
Lindhofer, Horst

Publication type:

Article

Correlation between melatonin concentration and cytokines in cervical mucus in positive samples for the presence of human papillomavirus.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2721, doi. 10.1007/s00262-021-02922-7

By:

Cotrim, Aron Carlos de Melo;
França, Eduardo Luzia;
Martins, Jordana Santos;
Silva, Katleyn Polizeli Galvão;
Fujimori, Mahmi;
Ghalfi, Yehya Chakib;
Machado, Izabela Trindade;
Honorio-França, Adenilda Cristina;
Tozetti, Inês Aparecida

Publication type:

Article

Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2429, doi. 10.1007/s00262-021-02916-5

By:

Sangaletti, Sabina;
Ferrara, Roberto;
Tripodo, Claudio;
Garassino, Marina Chiara;
Colombo, Mario Paolo

Publication type:

Article

Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2439, doi. 10.1007/s00262-021-02908-5

By:

Good, Logan;
Benner, Brooke;
Carson, William E.

Publication type:

Article

Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2701, doi. 10.1007/s00262-021-03001-7

By:

McArdel, Shannon L.;
Dugast, Anne-Sophie;
Hoover, Maegan E.;
Bollampalli, Arjun;
Hong, Enping;
Castano, Zafira;
Leonard, Shannon Curtis;
Pawar, Sneha;
Mellen, Jennifer;
Muriuki, Kelvin;
McLaughlin, Douglas C.;
Bayhi, Nicholas;
Carpenter, Christopher L.;
Turka, Laurence A.;
Wickham, Thomas J.;
Elloul, Sivan

Publication type:

Article

Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2641, doi. 10.1007/s00262-021-02884-w

By:

Mori, Keiichiro;
Resch, Irene;
Miura, Noriyoshi;
Laukhtina, Ekaterina;
Schuettfort, Victor M.;
Pradere, Benjamin;
Katayama, Satoshi;
D'Andrea, David;
Kardoust Parizi, Mehdi;
Abufaraj, Mohammad;
Fukuokaya, Wataru;
Collà Ruvolo, Claudia;
Luzzago, Stefano;
Knipper, Sophie;
Palumbo, Carlotta;
Karakiewicz, Pierre I.;
Briganti, Alberto;
Enikeev, Dmitry V.;
Rouprêt, Morgan;
Margulis, Vitaly

Publication type:

Article

Heterogeneity of PD-L1 expression between invasive and lepidic components of lung adenocarcinomas.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2651, doi. 10.1007/s00262-021-02883-x

By:

Hazim, Antonious;
Majithia, Neil;
Murphy, Stephen J.;
Wigle, Dennis;
Aubry, Marie-Christine;
Mansfield, Aaron S.

Publication type:

Article

Metabolic profiles of regulatory T cells in the tumour microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2417, doi. 10.1007/s00262-021-02881-z

By:

Rao, Disha;
Verburg, Fabienne;
Renner, Kathrin;
Peeper, Daniel S.;
Lacroix, Ruben;
Blank, Christian U.

Publication type:

Article

Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2625, doi. 10.1007/s00262-021-02879-7

By:

Saleh, Reem;
Sasidharan Nair, Varun;
Murshed, Khaled;
Abu Nada, Mohamed;
Elkord, Eyad;
Shaheen, Ranad

Publication type:

Article

Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2669, doi. 10.1007/s00262-021-02878-8

By:

Zhao, Chuanhua;
Wu, Lihong;
Liang, Dandan;
Chen, Huan;
Ji, Shoujian;
Zhang, Guanxiong;
Yang, Keyan;
Hu, Ying;
Mao, Beibei;
Liu, Tianshu;
Yu, Yiyi;
Zhang, Henghui;
Xu, Jianming

Publication type:

Article

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2617, doi. 10.1007/s00262-021-02876-w

By:

Boye, Kjetil;
Longhi, Alessandra;
Guren, Tormod;
Lorenz, Susanne;
Næss, Stine;
Pierini, Michela;
Taksdal, Ingeborg;
Lobmaier, Ingvild;
Cesari, Marilena;
Paioli, Anna;
Løndalen, Ayca M.;
Setola, Elisabetta;
Hompland, Ivar;
Meza-Zepeda, Leonardo A.;
Sundby Hall, Kirsten;
Palmerini, Emanuela

Publication type:

Article

Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2497, doi. 10.1007/s00262-021-02875-x

By:

Khaddour, Karam;
Khanna, Sangeeta;
Ansstas, Michael;
Jakhar, Ishaan;
Dahiya, Sonika;
Council, Laurin;
Ansstas, George

Publication type:

Article

The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2545, doi. 10.1007/s00262-021-02874-y

By:

Koucký, Vladimír;
Hladíková, Kamila;
Táborská, Eliška;
Bouček, Jan;
Grega, Marek;
Špíšek, Radek;
Fialová, Anna

Publication type:

Article

Regulatory T cells promote glioma cell stemness through TGF-β–NF-κB–IL6–STAT3 signaling.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2601, doi. 10.1007/s00262-021-02872-0

By:

Liu, Shasha;
Zhang, Chaoqi;
Wang, Boqiao;
Zhang, Huanyu;
Qin, Guohui;
Li, Congcong;
Cao, Ling;
Gao, Qun;
Ping, Yu;
Zhang, Kai;
Lian, Jingyao;
Zhao, Qitai;
Wang, Dan;
Zhang, Zhen;
Zhao, Xuan;
Yang, Li;
Huang, Lan;
Yang, Bo;
Zhang, Yi

Publication type:

Article

The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8+ T cells.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2529, doi. 10.1007/s00262-021-02870-2

By:

Shiga, Masanobu;
Miyazaki, Jun;
Tanuma, Kozaburo;
Nagumo, Yoshiyuki;
Yoshino, Takayuki;
Kandori, Shuya;
Negoro, Hiromitsu;
Kojima, Takahiro;
Tanaka, Ryota;
Okiyama, Naoko;
Fujisawa, Yasuhiro;
Watanabe, Miyuki;
Yamasaki, Sho;
Kiyohara, Hideyasu;
Watanabe, Makoto;
Sato, Taka-aki;
Tahara, Hideaki;
Nishiyama, Hiroyuki;
Yano, Ikuya

Publication type:

Article

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2517, doi. 10.1007/s00262-021-02869-9

By:

Zhang, Xiangyu;
Zeng, Liang;
Li, Yizhi;
Xu, Qinqin;
Yang, Haiyan;
Lizaso, Analyn;
Mao, Xinru;
Jin, Ren'an;
Zeng, Yu;
Li, Qinglin;
Wang, Jianbo;
Li, Yang;
Zhang, Yongchang;
Yang, Nong

Publication type:

Article

Platelet-expressed immune checkpoint regulator GITRL in breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2483, doi. 10.1007/s00262-021-02866-y

By:

Zhou, Yanjun;
Heitmann, Jonas S.;
Clar, Kim L.;
Kropp, Korbinian N.;
Hinterleitner, Martina;
Engler, Tobias;
Koch, André;
Hartkopf, Andreas D.;
Zender, Lars;
Salih, Helmut R.;
Maurer, Stefanie;
Hinterleitner, Clemens

Publication type:

Article

Novel roles of VAT1 expression in the immunosuppressive action of diffuse gliomas.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2589, doi. 10.1007/s00262-021-02865-z

By:

Yang, Pei;
Wang, Kuanyu;
Zhang, Chuanbao;
Wang, Zhiliang;
Liu, Qi;
Wang, Jiangfei;
Jiang, Tao;
Shan, Xia

Publication type:

Article

Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2681, doi. 10.1007/s00262-021-02863-1

By:

Zadka, Łukasz;
Chabowski, Mariusz;
Grybowski, Damian;
Piotrowska, Aleksandra;
Dzięgiel, Piotr

Publication type:

Article

IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2467, doi. 10.1007/s00262-021-02860-4

By:

Yang, Min;
Giehl, Esther;
Feng, Chao;
Feist, Mathilde;
Chen, Hongqi;
Dai, Enyong;
Liu, Zuqiang;
Ma, Congrong;
Ravindranathan, Roshni;
Bartlett, David L.;
Lu, Binfeng;
Guo, Zong Sheng

Publication type:

Article

Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2453, doi. 10.1007/s00262-021-02856-0

By:

Huang, Jianhan;
Zheng, Meijun;
Zhang, Zongliang;
Tang, Xin;
Chen, Yaxing;
Peng, Aijun;
Peng, Xingchen;
Tong, Aiping;
Zhou, Liangxue

Publication type:

Article

Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2503, doi. 10.1007/s00262-021-02853-3

By:

Goto, Shunsuke;
Sakoda, Yukimi;
Adachi, Keishi;
Sekido, Yoshitaka;
Yano, Seiji;
Eto, Masatoshi;
Tamada, Koji

Publication type:

Article

Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2657, doi. 10.1007/s00262-020-02827-x

By:

Chen, Junyu;
Zhong, Wenlong;
Yang, Meng;
Hou, Weibin;
Wang, Xiaofei;
Xia, Kun;
Yu, Hao;
Yang, Meihua;
Zhou, Bingkun;
Wang, Bo;
Huang, Jian;
Lin, Tianxin

Publication type:

Article

PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2577, doi. 10.1007/s00262-020-02825-z

By:

Goldmann, Torsten;
Marwitz, Sebastian;
Nitschkowski, Dörte;
Krupar, Rosemarie;
Backman, Max;
Elfving, Hedvig;
Thurfjell, Viktoria;
Lindberg, Amanda;
Brunnström, Hans;
La Fleur, Linnea;
Mezheyeuski, Artur;
Mattsson, Johanna Sofia Margareta;
Botling, Johan;
Micke, Patrick;
Strell, Carina

Publication type:

Article

Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2559, doi. 10.1007/s00262-020-02803-5

By:

Zhong, Li;
Wu, Qing;
Chen, Fuchun;
Liu, Junjin;
Xie, Xianhe

Publication type:

Article

Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 9

Correction to: Transcriptome of CD8<sup>+</sup> tumor-infiltrating T cells: a link between diabetes and colorectal cancer.

First time intravesically administered trifunctional antibody catumaxomab in patients with recurrent non-muscle invasive bladder cancer indicates high tolerability and local immunological activity.

Correlation between melatonin concentration and cytokines in cervical mucus in positive samples for the presence of human papillomavirus.

Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.

Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment.

Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15.

Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration.

Heterogeneity of PD-L1 expression between invasive and lepidic components of lung adenocarcinomas.

Metabolic profiles of regulatory T cells in the tumour microenvironment.

Transcriptome of CD8<sup>+</sup> tumor-infiltrating T cells: a link between diabetes and colorectal cancer.

Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers.

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.

Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanoma.

The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC.

Regulatory T cells promote glioma cell stemness through TGF-β–NF-κB–IL6–STAT3 signaling.

The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8<sup>+</sup> T cells.

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China.

Platelet-expressed immune checkpoint regulator GITRL in breast cancer.

Novel roles of VAT1 expression in the immunosuppressive action of diffuse gliomas.

Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer.

IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity.

Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma.

Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models.

Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy.

PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung.

Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors.